午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Imiquimod maleate
Imiquimod maleate
  • Imiquimod maleate

Imiquimod maleate NEW

Price $29 $39
Package 25mg 50mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-07-16

Product Details

Product Name: Imiquimod maleate CAS No.: 896106-16-4
Purity: 99.98% Supply Ability: 10g
Release date: 2025/07/16

Product Introduction

Bioactivity

NameImiquimod maleate
DescriptionImiquimod maleate (R 837 maleate) is a toll-like receptor 7 (TLR7) agonist and immune response modifier with antiviral and antitumor effects. Imiquimod maleate induces psoriatic-like skin lesions in mice and can be used to study various skin malignancies.
In vivoIn animal models, Imiquimod maleate stimulates the innate immune response by increasing NK cell activity, activating macrophages to secrete cytokines and nitric oxide, including interferon-a (IFN-α), interleukin (IL)-6, and tumour necrosis factor (TNF)-α, and inducing proliferation and differentiation of B lymphocytes. [1]
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationDMSO : 20 mg/mL (56.12 mM.), Sonication is recommended.
H2O : 1 mg/mL (2.81 mM.), Sonication is recommended.
KeywordsToll-like Receptor (TLR) | SARS-CoV | SARSCoV | HSV | Autophagy
Inhibitors RelatedStavudine | Cysteamine hydrochloride | Sodium 4-phenylbutyrate | Hydroxychloroquine | Guanidine hydrochloride | Taurine | Valproic Acid | Curcumin | Paeonol | Naringin | Alginic acid | Gefitinib
Related Compound LibrariesFDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Anti-Viral Compound Library | Drug Repurposing Compound Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1kg
VIP1Y
Shaanxi Xianhe Biotech Co., Ltd
2025-04-30
$65.00/10g
VIP5Y
Baoji Guokang Bio-Technology Co., Ltd.
2021-06-02
$/
VIP5Y
RongNa Biotechnology Co.,Ltd
2025-04-29
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY